Reviewed by Russell Noga, Licensed Medicare Insurance Broker (all 50 states) — Last updated November 12, 2026
Key Takeaway
Manhattan Life is a New York insurer founded in 1850 and now run from Houston, rated B++ (Good) by AM Best, and it is a sound but mid-tier Medicare Supplement company that no longer takes new Medigap applications. It stopped new sales in every state on April 30, 2025; existing policies stay in force and are still serviced, so this review is mainly for current policyholders.
2027 by the Numbers
B++
AM Best financial strength for ManhattanLife’s insurers, affirmed Dec. 3, 2025 (AM Best)
0
States taking new ManhattanLife Medigap applications since April 30, 2025 (carrier notice to agents)
~13.1%
Policy-weighted rate change across its four Medigap insurers in Tennessee’s 2023–24 report (our math, TN SERFF data)
81.6%
Share of Manhattan Life Group owned by chairman David W. Harris (New York DFS exam, as of 2021)
Search for Manhattan Life Medicare Supplement reviews and most of what comes up still describes a low-priced Plan G you can buy today. That stopped being true in spring 2025, when the company closed its Medigap product to new applicants nationwide.
This review relies on regulator records instead: AM Best, New York’s financial exam, Tennessee’s rate report and Missouri’s complaint files.


